Strata Critical Medical Inc.
SRTA | NASDAQ
$5.41
+$0.01 (+0.19%)
Sep 22, 2026, 2:11 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Sep 29, 2021 | FY 2020 Sep 29, 2020 |
|---|---|---|---|---|---|---|
Revenue | 197.14M | 248.69M | 225.18M | 146.12M | 50.53M | 23.43M |
Cost of Revenue | 156.02M | 189.77M | 183.06M | 123.85M | 40.01M | 21.11M |
Gross Profit | 41.13M | 58.92M | 42.12M | 22.28M | 10.52M | 2.33M |
Operating Income | -22.35M | -33.93M | -68.12M | -53.53M | -24.09M | -10.36M |
Interest Income | 4.24M | 7.21M | 8.44M | 3.43M | 460K | 200K |
Pretax Income | -20.07M | -27.56M | -57.54M | -28.03M | -43.7M | -10.16M |
Net Income | 41.35M | -27.31M | -56.08M | -27.26M | -40.05M | -10.16M |
Selling & General & Admin | 60.88M | 89.66M | 105.61M | 70.26M | 32.93M | 11.83M |
Research & Development | 3.05M | 3.18M | 4.63M | 5.55M | 1.68M | 861K |
Other Expenses | -448K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 63.48M | 92.85M | 110.24M | 75.8M | 34.61M | 12.69M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1K |
Selling & Marketing Expenses | n/a | 7.95M | 10.44M | 7.75M | 2.79M | 2.53M |
Cost & Expenses | 219.49M | 282.62M | 293.3M | 199.65M | 74.62M | 33.79M |
Income Tax Expense | n/a | -255K | -1.47M | -772K | -3.64M | n/a |
Shares Outstanding (Basic) | 82.45M | 77.5M | 73.52M | 71.24M | 70.1M | 12.51M |
Shares Outstanding (Diluted) | 82.45M | 77.5M | 73.52M | 71.24M | 70.1M | 12.51M |
EPS (Basic) | -0.19 | -0.35 | -0.76 | -0.38 | -0.57 | -0.81 |
EPS (Diluted) | -0.19 | -0.35 | -0.76 | -0.38 | -0.57 | -0.81 |
EBITDA | -5.71M | -21.6M | -50.43M | -22.31M | -43.1M | -9.83M |
EBIT | -12.61M | -27.56M | -57.54M | -28.03M | -43.7M | -10.36M |
Depreciation & Amortization | 6.9M | 5.96M | 7.11M | 5.73M | 596K | 526K |
Add to Watchlist
Select watchlists to add or remove SRTA